Improving reconstituted HDL composition for efficient post-ischemic reduction of ischemia reperfusion injury

PloS One
Marie-Claude Brulhart-MeynetMiguel A Frias

Abstract

New evidence shows that high density lipoproteins (HDL) have protective effects beyond their role in reverse cholesterol transport. Reconstituted HDL (rHDL) offer an attractive means of clinically exploiting these novel effects including cardioprotection against ischemia reperfusion injury (IRI). However, basic rHDL composition is limited to apolipoprotein AI (apoAI) and phospholipids; addition of bioactive compound may enhance its beneficial effects. The aim of this study was to investigate the role of rHDL in post-ischemic model, and to analyze the potential impact of sphingosine-1-phosphate (S1P) in rHDL formulations. The impact of HDL on IRI was investigated using complementary in vivo, ex vivo and in vitro IRI models. Acute post-ischemic treatment with native HDL significantly reduced infarct size and cell death in the ex vivo, isolated heart (Langendorff) model and the in vivo model (-48%, p<0.01). Treatment with rHDL of basic formulation (apoAI + phospholipids) had a non-significant impact on cell death in vitro and on the infarct size ex vivo and in vivo. In contrast, rHDL containing S1P had a highly significant, protective influence ex vivo, and in vivo (-50%, p<0.01). This impact was comparable with the effects observ...Continue Reading

References

Jan 1, 1986·Methods in Enzymology·A Jonas
Oct 21, 2003·The Journal of Pharmacology and Experimental Therapeutics·Giuseppe RossoniLaura Calabresi
Nov 6, 2003·JAMA : the Journal of the American Medical Association·Steven E NissenRichard Kerensky
Mar 28, 2007·JAMA : the Journal of the American Medical Association·Jean-Claude TardifUNKNOWN Effect of rHDL on Atherosclerosis-Safety and Efficacy (ERASE) Investigators
Nov 7, 2007·The New England Journal of Medicine·Philip J BarterUNKNOWN ILLUMINATE Investigators
Jun 24, 2008·Cardiovascular Research·Miguel A FriasUrsula Lang
Aug 12, 2009·Journal of Molecular and Cellular Cardiology·Vincent BraunersreutherClaire Arnaud
Aug 25, 2009·Cardiovascular Research·Miguel A FriasRichard W James
Jan 12, 2010·American Journal of Physiology. Heart and Circulatory Physiology·Rong TaoRobert Raffai
Jul 24, 2010·Basic Research in Cardiology·Katherine J E SattlerBodo Levkau
Sep 16, 2010·Cardiovascular Therapeutics·Rémy ChenevardFrank Ruschitzka
Mar 7, 2012·Cardiovascular Drugs and Therapy·Sarin J SomersSandrine Lecour
Mar 29, 2012·Antioxidants & Redox Signaling·Fabrizio MontecuccoAlessio Nencioni
Mar 19, 2013·Atherosclerosis·Miguel A FriasSandrine Lecour
Jun 22, 2014·Journal of Lipid Research·Iryna SutterArnold von Eckardstein
Jul 1, 2014·Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology·Katherine SattlerBodo Levkau

❮ Previous
Next ❯

Citations

Feb 3, 2016·Frontiers in Pharmacology·Monica GomaraschiGuido Franceschini
Mar 15, 2016·Translational Research : the Journal of Laboratory and Clinical Medicine·Wijtske Annema, Arnold von Eckardstein
Mar 29, 2016·Basic Research in Cardiology·K E O'SullivanJ P Hurley
Oct 13, 2017·Science Translational Medicine·Sarah E HeywoodBronwyn A Kingwell
May 26, 2017·Arteriosclerosis, Thrombosis, and Vascular Biology·Sylvain Galvani, Timothy Hla
Jan 18, 2018·Basic Research in Cardiology·Nkanyiso HadebeSandrine Lecour
Oct 12, 2018·Lipids in Health and Disease·Nicholas J WoudbergSandrine Lecour
Nov 27, 2019·British Journal of Pharmacology·Ioanna AndreadouPéter Ferdinandy
Jan 26, 2020·International Journal of Molecular Sciences·Soumaya Ben-AichaGemma Vilahur
Dec 18, 2019·International Journal of Molecular Sciences·Elena M G Diarte-AñazcoJosep Julve
Feb 7, 2018·Frontiers in Pharmacology·Nicholas J WoudbergMiguel A Frias
Nov 20, 2015·Frontiers in Pharmacology·Andrew L SiebelBronwyn A Kingwell
Nov 20, 2016·European Journal of Clinical Investigation·Miguel A FriasJonas W Brinck
Aug 6, 2019·Frontiers in Immunology·Andreas WeigertBernhard Brüne
Apr 1, 2016·Current Opinion in Lipidology·Arnold von Eckardstein, Lucia Rohrer
Oct 17, 2019·International Journal of Molecular Sciences·Andrea CaccioppoMaria Felice Brizzi
Dec 3, 2020·Biomedicines·Andrea Bonnin MárquezEmiel P.C. van der Vorst
Jan 13, 2021·Journal of Cellular Physiology·Federica CirilloLuigi Anastasia

❮ Previous
Next ❯

Methods Mentioned

BETA
ELISA
electrophoresis

Software Mentioned

MetaMorph
Boreal
GraphPad Prism
Planimetry +

Related Concepts

Related Feeds

Bioinformatics in Biomedicine

Bioinformatics in biomedicine incorporates computer science, biology, chemistry, medicine, mathematics and statistics. Discover the latest research on bioinformatics in biomedicine here.

Carotid Artery Diseases

Carotid artery disease is a group of pathological conditions of the carotid artery. Discover the latest research on carotid artery disease here.

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.